Literature DB >> 2354098

Effects of midazolam on median nerve somatosensory evoked potentials.

T B Sloan1, M L Fugina, J R Toleikis.   

Abstract

We have studied the effect of i.v. midazolam on median nerve somatosensory evoked potentials (SSEP) in 10 unpremedicated adults. Anaesthesia was induced with midazolam by bolus administration (0.2 mg kg-1) followed by infusion (5 mg h-1). The latency and amplitudes of the SSEP responses over the second cervical vertebrae (SC2) and sensory cortex (P17, N20, P25) were recorded before and for 10 min after induction. Data were analysed over that period for time-related alterations. Small but statistically significant increases in latency of the cortical N20 (P less than 0.005) and P25 (P less than 0.001) waves and interwave conduction times of SC2 to P25 (P less than 0.005) and N20 to P25 (P less than 0.021) were observed. Cortical amplitude (N20-P25) decreased significantly (P less than 0.012), to approximately 60% of baseline. These results demonstrated that midazolam produced a depression of cortical SSEP amplitude without clinically significant alterations in latency.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354098     DOI: 10.1093/bja/64.5.590

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  11 in total

1.  Intraoperative monitoring using somatosensory evoked potentials. A position statement by the American Society of Neurophysiological Monitoring.

Authors:  J Richard Toleikis
Journal:  J Clin Monit Comput       Date:  2005-06       Impact factor: 2.502

Review 2.  Neurological Prognostication in Children After Cardiac Arrest.

Authors:  Alyssa E Smith; Stuart H Friess
Journal:  Pediatr Neurol       Date:  2020-03-15       Impact factor: 3.372

3.  The effect of midazolam on median nerve somatosensory evoked potentials.

Authors:  K Lauer; C Munshi; S Larson
Journal:  J Clin Monit       Date:  1994-05

Review 4.  [Intraoperative electrophysiological monitoring with evoked potentials].

Authors:  R Nitzschke; N Hansen-Algenstaedt; J Regelsberger; A E Goetz; M S Goepfert
Journal:  Anaesthesist       Date:  2012-04       Impact factor: 1.041

Review 5.  Anesthesia and intraoperative neurophysiological monitoring in children.

Authors:  Tod Sloan
Journal:  Childs Nerv Syst       Date:  2009-11-04       Impact factor: 1.475

6.  Hypothermia after CPR prolongs conduction times of somatosensory evoked potentials.

Authors:  Aline Bouwes; Patty G G Doesborg; D Martin Laman; Johannes H T M Koelman; Jaap G Imanse; Selma C Tromp; Björn M van Geel; Elly L van der Kooi; Eveline G J Zandbergen; Janneke Horn
Journal:  Neurocrit Care       Date:  2013-08       Impact factor: 3.210

7.  Effects of benzodiazepines on mid-latency auditory evoked potentials.

Authors:  D Schwender; S Klasing; C Madler; E Pöppel; K Peter
Journal:  Can J Anaesth       Date:  1993-12       Impact factor: 5.063

8.  Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort study.

Authors:  Cédric Daubin; Charlotte Quentin; Stéphane Allouche; Olivier Etard; Cathy Gaillard; Amélie Seguin; Xavier Valette; Jean-Jacques Parienti; Fabrice Prevost; Michel Ramakers; Nicolas Terzi; Pierre Charbonneau; Damien du Cheyron
Journal:  BMC Cardiovasc Disord       Date:  2011-08-08       Impact factor: 2.298

9.  Predictive value of neurological examination for early cortical responses to somatosensory evoked potentials in patients with postanoxic coma.

Authors:  Aline Bouwes; Jan M Binnekade; Bart W Verbaan; Eveline G J Zandbergen; Johannes H T M Koelman; Henry C Weinstein; Albert Hijdra; Janneke Horn
Journal:  J Neurol       Date:  2011-09-02       Impact factor: 4.849

10.  A clinical and EEG scoring system that predicts early cortical response (N20) to somatosensory evoked potentials and outcome after cardiac arrest.

Authors:  Cédric Daubin; Damien Guillotin; Olivier Etard; Cathy Gaillard; Damien du Cheyron; Michel Ramakers; Bruno Bouchet; Jean-Jacques Parienti; Pierre Charbonneau
Journal:  BMC Cardiovasc Disord       Date:  2008-12-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.